Conference report: renal disease, metformin, and the adipocyte.
Bloomgarden
Z T
ZT
D017667:Adipocytes / Q000166:cytology* / Q000502:physiology*; D000818:Animals; D003920:Diabetes Mellitus; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000503:physiopathology*; D017127:Glycation End Products, Advanced; D006031:Glycosylation; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000503:physiopathology; D020738:Leptin; D008687:Metformin / Q000627:therapeutic use*; D051379:Mice; D008817:Mice, Mutant Strains; D008820:Mice, Obese; D009765:Obesity / Q000503:physiopathology; D014176:Protein Biosynthesis; D011506:Proteins / Q000494:pharmacology
D017127:Glycation End Products, Advanced; D007004:Hypoglycemic Agents; D020738:Leptin; D011506:Proteins; D008687:Metformin